Astellas' ASP0113 Trial Failure Gives Merck's Prevymis Further CMV Boost

 
• By Sten Stovall
  
Basketball
Astellas And Vical Missed Targets In ASP0113 CMV Vaccine Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business